Rheumatology (musculoskeletal system / joints)
Permanent URI for this collection
Research outputs from the Rheumatology team at the RD&E.
Browse
Recent Submissions
Item Treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope(Oxford University Press, 2023-05-15) Zhao, S. S.; Harrison, S. R.; Chan, A.; Clarke, N.; Davis, C.; Eddison, J.; Gregory, W. J.; Jones, G. T.; Marzo-Ortega, H.; Murphy, D. J.; Sandhu, V.; Sengupta, R.; Siebert, S.; Thompson, B.; Webb, D.; Yates, M.; Gaffney, K.Pharmacological management has advanced considerably since the 2015 British Society for Rheumatology axial spondyloarthritis (axSpA) guideline to incorporate new classes of biologic DMARDs (bDMARDs, including biosimilars), targeted synthetic DMARDs (tsDMARDs) and treatment strategies such as drug tapering. The aim of this guideline is to provide an evidence-based update on pharmacological management of adults with axSpA (including AS and non-radiographic axSpA) using b/tsDMARDs. This guideline is aimed at health-care professionals in the UK who care directly for people with axSpA, including rheumatologists, rheumatology specialist nurses, allied health professionals, rheumatology specialty trainees and pharmacists; people living with axSpA; and other stakeholders, such as patient organizations and charities.Item Diagnosis of cauda equina syndrome in the emergency department(BMJ, 2023-09-01) Metcalfe, D.; Hoeritzauer, I.; Angus, M.; Novak, A.; Hutton, M.; Woodfield, J.Cauda equina syndrome (CES) is a spinal emergency that can be challenging to identify from among the many patients presenting to EDs with low back and/or radicular leg pain. This article presents a practical guide to the assessment and early management of patients with suspected CES as well as an up-to-date review of the most important studies in this area that should inform clinical practice in the ED.Item Saving the planet with reduced routine DMARD blood monitoring frequency(BMJ, 2023-07-01) Wood, N. A. E.; Farmer, L.; Croker, R.; Kyle, S.; Lewis, T.Item The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs(Oxford University Press, 2022-08-30) Tucker, L.; Allen, A.; Chandler, D.; Ciurtin, C.; Dick, A.; Foulkes, A.; Gullick, N.; Helliwell, P.; Jadon, D.; Jones, G.; Kyle, S.; Madhok, V.; McHugh, N.; Parkinson, A.; Raine, T.; Siebert, S.; Smith, C.; Tillett, W.; Coates, L. C.Item Executive summary: The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs(Oxford University Press, 2022-08-30) Tucker, L.; Allen, A.; Chandler, D.; Ciurtin, C.; Dick, A.; Foulkes, A.; Gullick, N.; Helliwell, P.; Jadon, D.; Jones, G.; Kyle, S.; Madhok, V.; McHugh, N.; Parkinson, A.; Raine, T.; Siebert, S.; Smith, C.; Tillett, W.; Coates, L. C.